🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
This is a single-center, open-label, phase I clinical trial aimed to evalua...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-08-01
Trial ID
NCT05507606
Treatments Being Tested
This study aims to evaluate the clinical feasibility of first-line immunoch...
Status
Not Yet Recruiting
Location
The Obstetrics and Gynecology Hospital of Fudan University
Start Date
2025-03-10
Trial ID
NCT06878196
Treatments Being Tested
The purpose of this study is to evaluate how the participant's disease (ova...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2009-03
Trial ID
NCT00866723
Treatments Being Tested
This study is phase II, open label, clinical trial to determine the efficac...
Status
Enrolling By Invitation
Location
Yonsei Severance Hospital
Start Date
2020-10-28
Trial ID
NCT04361370
Treatments Being Tested
Background: Colorectal cancer is a common cancer in the Unites States (U.S...
Status
Terminated
Location
Lombardi Comprehensive Cancer Center
Start Date
2017-04-05
Trial ID
NCT03050814
This phase Ib trial finds the best dose and side effects of ensartinib and ...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-03-18
Trial ID
NCT04837716
Treatments Being Tested
This randomized, Phase III, multicenter, open-label study designed to evalu...
Status
Unknown
Location
Samsung Medical Center
Start Date
2019-08-27
Trial ID
NCT03991403
Treatments Being Tested
This is a two-group, parallel, randomized, standard-control phase II study ...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-09-01
Trial ID
NCT05077839
Treatments Being Tested